Page last updated: 2024-10-25

chlorpyrifos and Burkitt Lymphoma

chlorpyrifos has been researched along with Burkitt Lymphoma in 1 studies

Chlorpyrifos: An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.
chlorpyrifos : An organic thiophosphate that is O,O-diethyl hydrogen phosphorothioate in which the hydrogen of the hydroxy group has been replaced by a 3,5,6-trichloropyridin-2-yl group.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research Excerpts

ExcerptRelevanceReference
"Flow cytometry is widely used for B-ALL minimal residual disease (MRD) analysis given its speed, availability, and sensitivity; however, distinguishing B-lymphoblasts from regenerative B-cells is not always straightforward."1.72Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual disease analysis. ( Al-Bakri, M; Liu, L; Setiadi, A; Shopsowitz, KE; Vercauteren, S, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shopsowitz, KE1
Liu, L1
Setiadi, A1
Al-Bakri, M1
Vercauteren, S1

Other Studies

1 other study available for chlorpyrifos and Burkitt Lymphoma

ArticleYear
Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual disease analysis.
    Cytometry. Part B, Clinical cytometry, 2022, Volume: 102, Issue:5

    Topics: Acute Disease; Burkitt Lymphoma; Child; Flow Cytometry; Humans; Machine Learning; Neoplasm, Residual

2022